US Stock MarketDetailed Quotes

LBPWQ 4D Pharma

Watchlist
  • 0.000100
  • 0.0000000.00%
15min DelayClose Feb 6 16:00 ET
0Market Cap0.00P/E (TTM)

4D Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
(FY)Dec 31, 2017
(FY)Dec 31, 2016
(FY)Dec 31, 2015
(FY)Dec 31, 2014
Total revenue
-2.25%522K
160.28%534K
205.16K
0
0
0
0
Operating revenue
-2.25%522K
160.28%534K
--205.16K
--0
----
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-3.27%27.05M
-7.34%27.97M
-2.11%30.18M
51.43%30.83M
55.57%20.36M
23.10%13.09M
206.13%10.63M
3.47M
Selling and administrative expenses
19.78%4.91M
-48.26%4.1M
-11.05%7.92M
318.26%8.9M
10.37%2.13M
8.38%1.93M
104.95%1.78M
--868K
-General and administrative expense
19.78%4.91M
-48.26%4.1M
-11.05%7.92M
318.26%8.9M
10.37%2.13M
8.38%1.93M
104.95%1.78M
--868K
Research and development costs
-10.09%19.82M
-1.01%22.04M
1.52%22.26M
29.69%21.93M
65.47%16.91M
21.87%10.22M
360.01%8.39M
--1.82M
-Depreciation and amortization
-18.37%231K
--283K
----
----
19.64%67K
1,766.67%56K
-97.37%3K
--114K
Operating profit
3.29%-26.53M
8.49%-27.43M
2.78%-29.98M
-51.43%-30.83M
-55.57%-20.36M
-23.10%-13.09M
-206.13%-10.63M
-3.47M
Net non-operating interest income expense
-262.50%-609K
-382.40%-168K
-79.92%59.49K
-17.46%296.32K
-38.21%359K
28.82%581K
418.39%451K
87K
Non-operating interest income
-80.00%1K
-91.60%5K
-80.08%59.49K
-38.03%298.68K
-26.07%482K
44.57%652K
390.22%451K
--92K
Non-operating interest expense
252.60%610K
--173K
----
-98.08%2.36K
73.24%123K
--71K
--0
--5K
Other net income (expense)
Special income (charges)
-1,327.49%-44.4M
-237.44%-3.11M
717.50%2.26M
89.69%-366.46K
-177,750.00%-3.55M
200.00%2K
-100.14%-2K
--1.39M
-Less:Restructuring and merger&acquisition
1,327.04%44.38M
237.44%3.11M
-717.50%-2.26M
-89.45%366.46K
--3.47M
--0
----
---1.39M
-Less:Other special charges
--14K
----
----
----
4,050.00%79K
-200.00%-2K
--2K
----
Other non- operating income (expenses)
----
----
4.44%5.25M
--5.03M
----
----
----
----
Income before tax
-89.37%-57.47M
-31.17%-30.35M
9.96%-23.13M
-7.11%-25.69M
-104.90%-23.99M
-16.37%-11.71M
-322.65%-10.06M
-2.38M
Income tax
20.03%-3.51M
-4.38M
0
0
-92.13%-3.54M
20.83%-1.84M
-2.33M
0
Net income
-107.83%-53.96M
-12.23%-25.96M
9.96%-23.13M
-25.66%-25.69M
-107.29%-20.45M
-27.58%-9.86M
-224.83%-7.73M
-2.38M
Net income continuous Operations
-107.83%-53.96M
-12.23%-25.96M
9.96%-23.13M
-25.66%-25.69M
-107.29%-20.45M
-27.58%-9.86M
-224.83%-7.73M
---2.38M
Minority interest income
48.75%-184K
-359K
Net income attributable to the parent company
-107.83%-53.96M
-12.23%-25.96M
9.96%-23.13M
-25.66%-25.69M
-107.29%-20.45M
-30.69%-9.86M
-273.43%-7.55M
-2.02M
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-107.83%-53.96M
-12.23%-25.96M
9.96%-23.13M
-25.66%-25.69M
-107.29%-20.45M
-30.69%-9.86M
-273.43%-7.55M
-2.02M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018(FY)Dec 31, 2017(FY)Dec 31, 2016(FY)Dec 31, 2015(FY)Dec 31, 2014
Total revenue -2.25%522K160.28%534K205.16K0000
Operating revenue -2.25%522K160.28%534K--205.16K--0------0--0--0
Cost of revenue
Gross profit
Operating expense -3.27%27.05M-7.34%27.97M-2.11%30.18M51.43%30.83M55.57%20.36M23.10%13.09M206.13%10.63M3.47M
Selling and administrative expenses 19.78%4.91M-48.26%4.1M-11.05%7.92M318.26%8.9M10.37%2.13M8.38%1.93M104.95%1.78M--868K
-General and administrative expense 19.78%4.91M-48.26%4.1M-11.05%7.92M318.26%8.9M10.37%2.13M8.38%1.93M104.95%1.78M--868K
Research and development costs -10.09%19.82M-1.01%22.04M1.52%22.26M29.69%21.93M65.47%16.91M21.87%10.22M360.01%8.39M--1.82M
-Depreciation and amortization -18.37%231K--283K--------19.64%67K1,766.67%56K-97.37%3K--114K
Operating profit 3.29%-26.53M8.49%-27.43M2.78%-29.98M-51.43%-30.83M-55.57%-20.36M-23.10%-13.09M-206.13%-10.63M-3.47M
Net non-operating interest income expense -262.50%-609K-382.40%-168K-79.92%59.49K-17.46%296.32K-38.21%359K28.82%581K418.39%451K87K
Non-operating interest income -80.00%1K-91.60%5K-80.08%59.49K-38.03%298.68K-26.07%482K44.57%652K390.22%451K--92K
Non-operating interest expense 252.60%610K--173K-----98.08%2.36K73.24%123K--71K--0--5K
Other net income (expense)
Special income (charges) -1,327.49%-44.4M-237.44%-3.11M717.50%2.26M89.69%-366.46K-177,750.00%-3.55M200.00%2K-100.14%-2K--1.39M
-Less:Restructuring and merger&acquisition 1,327.04%44.38M237.44%3.11M-717.50%-2.26M-89.45%366.46K--3.47M--0-------1.39M
-Less:Other special charges --14K------------4,050.00%79K-200.00%-2K--2K----
Other non- operating income (expenses) --------4.44%5.25M--5.03M----------------
Income before tax -89.37%-57.47M-31.17%-30.35M9.96%-23.13M-7.11%-25.69M-104.90%-23.99M-16.37%-11.71M-322.65%-10.06M-2.38M
Income tax 20.03%-3.51M-4.38M00-92.13%-3.54M20.83%-1.84M-2.33M0
Net income -107.83%-53.96M-12.23%-25.96M9.96%-23.13M-25.66%-25.69M-107.29%-20.45M-27.58%-9.86M-224.83%-7.73M-2.38M
Net income continuous Operations -107.83%-53.96M-12.23%-25.96M9.96%-23.13M-25.66%-25.69M-107.29%-20.45M-27.58%-9.86M-224.83%-7.73M---2.38M
Minority interest income 48.75%-184K-359K
Net income attributable to the parent company -107.83%-53.96M-12.23%-25.96M9.96%-23.13M-25.66%-25.69M-107.29%-20.45M-30.69%-9.86M-273.43%-7.55M-2.02M
Preferred stock dividends
Other preferred stock dividends 00000000
Net income attributable to common stockholders -107.83%-53.96M-12.23%-25.96M9.96%-23.13M-25.66%-25.69M-107.29%-20.45M-30.69%-9.86M-273.43%-7.55M-2.02M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit GBPGBPGBPGBPGBPGBPGBPGBP
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg